The technique employed for the screening of selective inhibitors of VIM-2 metallo-beta-lactamase is PubChem BioAssay. It is a high throughput screening assay with Epi-absorbance-based dose response biochemical method. The assay confirms the Direct single protein target assigned for the screening. The properties of the assay include: assay category as confirmatory, assay organism being Pseudomonas aeruginosa, and assay type description as Binding. Does this assay show effectiveness of the molecule?